Metformin-Associated Encephalopathy as a Rare but Serious Adverse Effect: A Case Report
Abstract
Metformin is widely prescribed as a first-line therapy for type 2 diabetes. Metformin-associated encephalopathy is a rare but serious adverse effect that can occur when the drug is inappropriately prescribed to patients with impaired renal function. Here we present the case of a 44-year-old woman undergoing maintenance hemodialysis for diabetic nephropathy who presented to the emergency department with dysarthria and generalized weakness. Although no paralysis was observed, she had difficulty maintaining posture and exhibited gait disturbance. Laboratory tests revealed metabolic acidosis (pH 7.197, bicarbonate 11.7 mmol/L) and hyperlactatemia (12.4 mmol/L). Brain magnetic resonance imaging (MRI) revealed hyperintensity in the bilateral basal ganglia. The patient had been taking metformin. Metformin was discontinued, and emergent hemodialysis was initiated, followed by continued maintenance hemodialysis; the patient's dysarthria, weakness, and abnormal findings on brain MRI subsequently rapidly improved, which confirmed the diagnosis of metformin-associated encephalopathy. Inappropriate prescription of metformin can lead to metformin-associated encephalopathy, a rare but serious adverse effect. Emergency physicians must carefully review of patients' medications and become familiar with the clinical and imaging features of metformin-associated encephalopathy.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.